25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Race Oncology Ltd
Buy, Hold or Sell?

Let's analyze Race Oncology Ltd together

I guess you are interested in Race Oncology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Race Oncology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Race Oncology Ltd

I send you an email if I find something interesting about Race Oncology Ltd.

1. Quick Overview

1.1. Quick analysis of Race Oncology Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Race Oncology Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.11
Expected worth in 1 year
A$-0.06
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$-0.17
Return On Investment
-10.0%

For what price can you sell your share?

Current Price per Share
A$1.69
Expected price per share
A$1.35 - A$2.09
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Race Oncology Ltd (5 min.)




Live pricePrice per Share (EOD)
A$1.69
Intrinsic Value Per Share
A$-0.73 - A$-0.47
Total Value Per Share
A$-0.62 - A$-0.36

2.2. Growth of Race Oncology Ltd (5 min.)




Is Race Oncology Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$12.2m$17m-$4.8m-39.2%

How much money is Race Oncology Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$9.2m-$6.6m-$2.6m-28.2%
Net Profit Margin0.0%-316.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Race Oncology Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#612 / 967

Most Revenue
#860 / 967

Most Profit
#552 / 967

Most Efficient
#226 / 967
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Race Oncology Ltd?

Welcome investor! Race Oncology Ltd's management wants to use your money to grow the business. In return you get a share of Race Oncology Ltd.

First you should know what it really means to hold a share of Race Oncology Ltd. And how you can make/lose money.

Speculation

The Price per Share of Race Oncology Ltd is A$1.685. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Race Oncology Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Race Oncology Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.11. Based on the TTM, the Book Value Change Per Share is A$-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Race Oncology Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.05-3.2%-0.05-3.2%-0.04-2.3%-0.04-2.1%-0.02-1.4%
Usd Book Value Change Per Share-0.03-1.7%-0.03-1.7%-0.04-2.5%0.010.6%0.010.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share-0.03-1.7%-0.03-1.7%-0.04-2.5%0.010.6%0.010.5%
Usd Price Per Share1.22-1.22-0.82-1.26-0.66-
Price to Earnings Ratio-22.50--22.50--21.04--40.57--22.02-
Price-to-Total Gains Ratio-43.35--43.35--19.65-43.21-30.86-
Price to Book Ratio16.98-16.98-8.19-20.18-11.40-
Price-to-Total Gains Ratio-43.35--43.35--19.65-43.21-30.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.129961
Number of shares884
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.01
Usd Total Gains Per Share-0.030.01
Gains per Quarter (884 shares)-24.969.23
Gains per Year (884 shares)-99.8236.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-100-11003727
20-200-21007464
30-299-3100111101
40-399-4100148138
50-499-5100185175
60-599-6100221212
70-699-7100258249
80-799-8100295286
90-898-9100332323
100-998-10100369360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.013.00.013.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.06.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%2.00.08.020.0%6.00.09.040.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.06.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Race Oncology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.042-0.0420%-0.062+48%0.016-370%0.011-490%
Book Value Per Share--0.1070.1070%0.150-28%0.117-8%0.072+50%
Current Ratio--9.3239.3230%20.442-54%16.460-43%11.699-20%
Debt To Asset Ratio--0.0950.0950%0.043+119%0.051+87%0.143-34%
Debt To Equity Ratio--0.1050.1050%0.045+132%0.054+94%2.139-95%
Dividend Per Share----0%-0%-0%0.003-100%
Eps---0.081-0.0810%-0.058-28%-0.053-35%-0.035-57%
Free Cash Flow Per Share---0.056-0.0560%-0.063+12%-0.039-30%-0.025-55%
Free Cash Flow To Equity Per Share---0.025-0.0250%-0.070+175%0.019-233%0.010-351%
Gross Profit Margin--1.0001.0000%1.033-3%1.021-2%1.088-8%
Intrinsic Value_10Y_max---0.466--------
Intrinsic Value_10Y_min---0.731--------
Intrinsic Value_1Y_max---0.030--------
Intrinsic Value_1Y_min---0.058--------
Intrinsic Value_3Y_max---0.103--------
Intrinsic Value_3Y_min---0.188--------
Intrinsic Value_5Y_max---0.191--------
Intrinsic Value_5Y_min---0.333--------
Market Cap287142548.480-8%311000089.600311000089.6000%208753484.800+49%319350228.992-3%167991171.686+85%
Net Profit Margin----0%-3.1660%-11.8980%-47.4840%
Operating Margin----0%-4.1430%-12.3880%-50.8600%
Operating Ratio----0%4.143-100%12.388-100%48.422-100%
Pb Ratio15.680-8%16.98316.9830%8.191+107%20.183-16%11.402+49%
Pe Ratio-20.778+8%-22.505-22.5050%-21.036-7%-40.572+80%-22.020-2%
Price Per Share1.685-8%1.8251.8250%1.225+49%1.874-3%0.986+85%
Price To Free Cash Flow Ratio-30.081+8%-32.581-32.5810%-19.598-40%-57.369+76%-31.502-3%
Price To Total Gains Ratio-40.025+8%-43.351-43.3510%-19.654-55%43.210-200%30.855-240%
Quick Ratio--17.71517.7150%37.181-52%24.675-28%15.761+12%
Return On Assets---0.683-0.6830%-0.373-45%-0.489-28%-0.538-21%
Return On Equity---0.755-0.7550%-0.389-48%-0.518-31%-2.028+169%
Total Gains Per Share---0.042-0.0420%-0.062+48%0.016-370%0.014-405%
Usd Book Value--12280126.44912280126.4490%17091006.155-28%13320556.716-8%8182639.271+50%
Usd Book Value Change Per Share---0.028-0.0280%-0.042+48%0.010-370%0.007-490%
Usd Book Value Per Share--0.0720.0720%0.100-28%0.078-8%0.048+50%
Usd Dividend Per Share----0%-0%-0%0.002-100%
Usd Eps---0.054-0.0540%-0.039-28%-0.036-35%-0.023-57%
Usd Free Cash Flow---6401265.277-6401265.2770%-7142930.101+12%-4508528.027-30%-2885921.735-55%
Usd Free Cash Flow Per Share---0.038-0.0380%-0.042+12%-0.026-30%-0.017-55%
Usd Free Cash Flow To Equity Per Share---0.017-0.0170%-0.047+175%0.013-233%0.007-351%
Usd Market Cap192557793.011-8%208556660.086208556660.0860%139990086.907+49%214156263.562-3%112654879.733+85%
Usd Price Per Share1.130-8%1.2241.2240%0.821+49%1.257-3%0.661+85%
Usd Profit---9267246.722-9267246.7220%-6654648.805-28%-6052972.805-35%-4001710.677-57%
Usd Revenue----0%2101915.899-100%588645.169-100%323925.752-100%
Usd Total Gains Per Share---0.028-0.0280%-0.042+48%0.010-370%0.009-405%
 EOD+3 -5MRQTTM+0 -0YOY+15 -175Y+3 -2910Y+13 -21

3.3 Fundamental Score

Let's check the fundamental score of Race Oncology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-20.778
Price to Book Ratio (EOD)Between0-115.680
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than117.715
Current Ratio (MRQ)Greater than19.323
Debt to Asset Ratio (MRQ)Less than10.095
Debt to Equity Ratio (MRQ)Less than10.105
Return on Equity (MRQ)Greater than0.15-0.755
Return on Assets (MRQ)Greater than0.05-0.683
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Race Oncology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.487
Ma 20Greater thanMa 501.629
Ma 50Greater thanMa 1001.643
Ma 100Greater thanMa 2001.613
OpenGreater thanClose1.690
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Race Oncology Ltd

Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on cancer care. Its lead product is bisantrene, a small molecule chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications; delivers cardioprotection; and improves anti-cancer activity in solid tumors. It is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway, following independent research describing bisantrene as the potent inhibitor of fat mass and obesity-associated protein (FTO). The company is in collaboration with City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-09-09 19:28:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Race Oncology Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Race Oncology Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-316.6%+316.6%
TTM-5Y-1,189.8%+1,189.8%
5Y-1,189.8%10Y-4,748.4%+3,558.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--132.1%+132.1%
TTM--212.2%+212.2%
YOY-316.6%-221.9%-94.7%
5Y-1,189.8%-373.2%-816.6%
10Y-4,748.4%-490.1%-4,258.3%
4.3.1.2. Return on Assets

Shows how efficient Race Oncology Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • -68.3% Return on Assets means that Race Oncology Ltd generated $-0.68 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Race Oncology Ltd:

  • The MRQ is -68.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -68.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-68.3%TTM-68.3%0.0%
TTM-68.3%YOY-37.3%-31.1%
TTM-68.3%5Y-48.9%-19.4%
5Y-48.9%10Y-53.8%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.3%-11.1%-57.2%
TTM-68.3%-11.7%-56.6%
YOY-37.3%-11.2%-26.1%
5Y-48.9%-12.9%-36.0%
10Y-53.8%-14.4%-39.4%
4.3.1.3. Return on Equity

Shows how efficient Race Oncology Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • -75.5% Return on Equity means Race Oncology Ltd generated $-0.75 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Race Oncology Ltd:

  • The MRQ is -75.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -75.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-75.5%TTM-75.5%0.0%
TTM-75.5%YOY-38.9%-36.5%
TTM-75.5%5Y-51.8%-23.6%
5Y-51.8%10Y-202.8%+150.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.5%-13.6%-61.9%
TTM-75.5%-16.1%-59.4%
YOY-38.9%-13.6%-25.3%
5Y-51.8%-18.9%-32.9%
10Y-202.8%-19.1%-183.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Race Oncology Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Race Oncology Ltd is operating .

  • Measures how much profit Race Oncology Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Race Oncology Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-414.3%+414.3%
TTM-5Y-1,238.8%+1,238.8%
5Y-1,238.8%10Y-5,086.0%+3,847.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.8%+277.8%
TTM--279.2%+279.2%
YOY-414.3%-234.1%-180.2%
5Y-1,238.8%-388.9%-849.9%
10Y-5,086.0%-496.6%-4,589.4%
4.3.2.2. Operating Ratio

Measures how efficient Race Oncology Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Race Oncology Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.143-4.143
TTM-5Y12.388-12.388
5Y12.38810Y48.422-36.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.761-2.761
TTM-3.321-3.321
YOY4.1433.430+0.713
5Y12.3885.021+7.367
10Y48.4226.570+41.852
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Race Oncology Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Race Oncology Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.32 means the company has $9.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Race Oncology Ltd:

  • The MRQ is 9.323. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.323. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.323TTM9.3230.000
TTM9.323YOY20.442-11.119
TTM9.3235Y16.460-7.137
5Y16.46010Y11.699+4.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3233.734+5.589
TTM9.3233.909+5.414
YOY20.4424.740+15.702
5Y16.4605.955+10.505
10Y11.6996.303+5.396
4.4.3.2. Quick Ratio

Measures if Race Oncology Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 17.71 means the company can pay off $17.71 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Race Oncology Ltd:

  • The MRQ is 17.715. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 17.715. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ17.715TTM17.7150.000
TTM17.715YOY37.181-19.466
TTM17.7155Y24.675-6.961
5Y24.67510Y15.761+8.914
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.7153.134+14.581
TTM17.7153.444+14.271
YOY37.1814.693+32.488
5Y24.6755.867+18.808
10Y15.7616.479+9.282
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Race Oncology Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Race Oncology Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Race Oncology Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Race Oncology Ltd assets are financed with 9.5% credit (debt) and the remaining percentage (100% - 9.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Race Oncology Ltd:

  • The MRQ is 0.095. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.095. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.095TTM0.0950.000
TTM0.095YOY0.043+0.051
TTM0.0955Y0.051+0.044
5Y0.05110Y0.143-0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0950.343-0.248
TTM0.0950.346-0.251
YOY0.0430.306-0.263
5Y0.0510.365-0.314
10Y0.1430.382-0.239
4.5.4.2. Debt to Equity Ratio

Measures if Race Oncology Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.5% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Race Oncology Ltd:

  • The MRQ is 0.105. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.105. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.1050.000
TTM0.105YOY0.045+0.059
TTM0.1055Y0.054+0.051
5Y0.05410Y2.139-2.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.395-0.290
TTM0.1050.450-0.345
YOY0.0450.372-0.327
5Y0.0540.449-0.395
10Y2.1390.488+1.651
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Race Oncology Ltd generates.

  • Above 15 is considered overpriced but always compare Race Oncology Ltd to the Biotechnology industry mean.
  • A PE ratio of -22.50 means the investor is paying $-22.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Race Oncology Ltd:

  • The EOD is -20.778. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.505. Based on the earnings, the company is expensive. -2
  • The TTM is -22.505. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.778MRQ-22.505+1.726
MRQ-22.505TTM-22.5050.000
TTM-22.505YOY-21.036-1.468
TTM-22.5055Y-40.572+18.068
5Y-40.57210Y-22.020-18.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-20.778-2.335-18.443
MRQ-22.505-2.413-20.092
TTM-22.505-2.978-19.527
YOY-21.036-3.462-17.574
5Y-40.572-6.080-34.492
10Y-22.020-6.254-15.766
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Race Oncology Ltd:

  • The EOD is -30.081. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -32.581. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -32.581. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-30.081MRQ-32.581+2.499
MRQ-32.581TTM-32.5810.000
TTM-32.581YOY-19.598-12.982
TTM-32.5815Y-57.369+24.788
5Y-57.36910Y-31.502-25.867
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-30.081-3.054-27.027
MRQ-32.581-3.229-29.352
TTM-32.581-3.575-29.006
YOY-19.598-4.723-14.875
5Y-57.369-8.076-49.293
10Y-31.502-8.636-22.866
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Race Oncology Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 16.98 means the investor is paying $16.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Race Oncology Ltd:

  • The EOD is 15.680. Based on the equity, the company is expensive. -2
  • The MRQ is 16.983. Based on the equity, the company is expensive. -2
  • The TTM is 16.983. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.680MRQ16.983-1.303
MRQ16.983TTM16.9830.000
TTM16.983YOY8.191+8.792
TTM16.9835Y20.183-3.200
5Y20.18310Y11.402+8.781
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.6801.829+13.851
MRQ16.9831.903+15.080
TTM16.9832.225+14.758
YOY8.1912.412+5.779
5Y20.1833.546+16.637
10Y11.4024.109+7.293
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Race Oncology Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Other Income Expense Net -45-207-252-172-424353-718010



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets20,229
Total Liabilities1,916
Total Stockholder Equity18,312
 As reported
Total Liabilities 1,916
Total Stockholder Equity+ 18,312
Total Assets = 20,229

Assets

Total Assets20,229
Total Current Assets17,417
Long-term Assets2,812
Total Current Assets
Cash And Cash Equivalents 1,389
Short-term Investments 15,800
Net Receivables 106
Other Current Assets 122
Total Current Assets  (as reported)17,417
Total Current Assets  (calculated)17,417
+/-0
Long-term Assets
Long-term Assets  (as reported)2,812
Long-term Assets  (calculated)0
+/- 2,812

Liabilities & Shareholders' Equity

Total Current Liabilities1,868
Long-term Liabilities48
Total Stockholder Equity18,312
Total Current Liabilities
Accounts payable 1,199
Other Current Liabilities 669
Total Current Liabilities  (as reported)1,868
Total Current Liabilities  (calculated)1,868
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)48
Long-term Liabilities  (calculated)0
+/- 48
Total Stockholder Equity
Common Stock66,948
Retained Earnings -57,418
Accumulated Other Comprehensive Income 8,782
Total Stockholder Equity (as reported)18,312
Total Stockholder Equity (calculated)18,312
+/-0
Other
Cash and Short Term Investments 17,189
Common Stock Shares Outstanding 164,501
Liabilities and Stockholders Equity 20,229
Net Debt -1,389
Net Working Capital 15,548



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-12-312013-06-302012-12-312012-06-302011-06-30
> Total Assets 
380,251
425,961
360,834
105
289,974
62
124
4,470
6,001
8,240
5,242
5,934
14,246
37,525
26,638
20,229
20,22926,63837,52514,2465,9345,2428,2406,0014,47012462289,974105360,834425,961380,251
   > Total Current Assets 
175,587
306,641
219,536
105
168,926
62
124
4,470
1,751
3,741
1,024
1,997
10,590
34,150
23,545
17,417
17,41723,54534,15010,5901,9971,0243,7411,7514,47012462168,926105219,536306,641175,587
       Cash And Cash Equivalents 
10,305
40,140
19,131
104
25,616
48
21
4,349
1,697
3,710
989
1,731
9,322
6,041
1,920
1,389
1,3891,9206,0419,3221,7319893,7101,6974,349214825,61610419,13140,14010,305
       Short-term Investments 
30,918
60,000
10,000
0
9,992
0
0
0
0
0
0
0
0
27,500
19,600
15,800
15,80019,60027,500000000009,992010,00060,00030,918
       Net Receivables 
48,993
64,364
59,963
8
54,456
14
103
110
2
0
1
49
128
62
1,704
106
1061,70462128491021101031454,456859,96364,36448,993
       Other Current Assets 
84,588
141,219
129,625
1
77,960
14
103
120
54
31
35
217
1,139
547
320
122
1223205471,1392173531541201031477,9601129,625141,21984,588
   > Long-term Assets 
0
0
0
0
0
0
0
3,800
4,250
4,499
4,218
3,937
3,656
3,374
3,093
2,812
2,8123,0933,3743,6563,9374,2184,4994,2503,8000000000
       Property Plant Equipment 
2,848
2,477
2,180
0
1,817
0
0
0
0
0
0
0
0
0
0
0
000000000001,81702,1802,4772,848
       Goodwill 
34,371
34,371
34,371
0
34,371
0
0
0
0
0
0
0
0
0
0
0
0000000000034,371034,37134,37134,371
       Long Term Investments 
77,154
20,381
60,603
0
56,455
0
0
0
0
0
0
0
0
0
0
0
0000000000056,455060,60320,38177,154
       Intangible Assets 
35,861
37,346
25,650
0
17,584
0
0
3,000
4,250
4,499
4,218
3,937
3,656
3,374
3,093
0
03,0933,3743,6563,9374,2184,4994,2503,0000017,584025,65037,34635,861
       Long-term Assets Other 
0
0
0
0
0
0
0
800
-4,250
-4,499
-4,218
-3,937
-3,656
-3,374
-3,093
0
0-3,093-3,374-3,656-3,937-4,218-4,499-4,2508000000000
> Total Liabilities 
273,205
331,510
264,983
12
191,008
132
119
392
364
310
192
244
523
1,417
1,152
1,916
1,9161,1521,417523244192310364392119132191,00812264,983331,510273,205
   > Total Current Liabilities 
200,036
253,957
194,387
12
123,907
132
119
392
364
310
192
244
523
1,417
1,152
1,868
1,8681,1521,417523244192310364392119132123,90712194,387253,957200,036
       Short-term Debt 
5,000
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0000000050000005,000
       Short Long Term Debt 
5,000
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0000000050000005,000
       Accounts payable 
78,710
107,759
96,405
12
73,857
132
119
107
193
205
100
133
312
834
639
1,199
1,19963983431213310020519310711913273,8571296,405107,75978,710
       Other Current Liabilities 
120,852
145,650
97,422
0
49,679
0
0
284
171
105
92
111
211
584
513
669
669513584211111921051712840049,679097,422145,650120,852
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
100
133
312
834
0
48
4808343121331000000000000
       Deferred Long Term Liability 
18,325
20,995
14,744
0
7,071
0
0
0
0
0
0
0
0
0
0
0
000000000007,071014,74420,99518,325
> Total Stockholder Equity
107,046
94,451
95,851
93
98,966
-70
6
4,078
5,637
7,931
5,050
5,690
13,722
36,107
25,486
18,312
18,31225,48636,10713,7225,6905,0507,9315,6374,0786-7098,9669395,85194,451107,046
   Common Stock
99,615
99,539
99,539
110
99,539
110
273
4,663
8,493
14,456
15,423
19,660
31,495
62,017
61,709
66,948
66,94861,70962,01731,49519,66015,42314,4568,4934,66327311099,53911099,53999,53999,615
   Retained Earnings 
7,273
-5,086
-3,997
-17
117
-180
-268
-585
-4,757
-10,811
-13,428
-15,771
-22,466
-33,675
-43,599
-57,418
-57,418-43,599-33,675-22,466-15,771-13,428-10,811-4,757-585-268-180117-17-3,997-5,0867,273
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
160
0
379
-93
698
0
-6
-562
1,901
4,285
3,055
-3,889
-9,029
-28,341
-18,110
0
0-18,110-28,341-9,029-3,8893,0554,2851,901-562-60698-933790160



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.




5.6. Income Statements

All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-281
Gross Profit-281-281
 
Operating Income (+$)
Gross Profit-281
Operating Expense-17,551
Operating Income-17,833-17,833
 
Operating Expense (+$)
Research Development10,977
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense17,55110,977
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-17,833
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,823-17,842
EBIT - interestExpense = -17,833
-17,823
-13,819
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-17,833-17,823
Earnings Before Interest and Taxes (EBITDA)-17,551
 
After tax Income (+$)
Income Before Tax-17,823
Tax Provision-0
Net Income From Continuing Ops0-17,823
Net Income-13,819
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,833
Total Other Income/Expenses Net100
 

Technical Analysis of Race Oncology Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Race Oncology Ltd. The general trend of Race Oncology Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Race Oncology Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Race Oncology Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.79 < 1.97 < 2.09.

The bearish price targets are: 1.46 > 1.46 > 1.35.

Tweet this
Race Oncology Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Race Oncology Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Race Oncology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Race Oncology Ltd. The current macd is 0.01835752.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Race Oncology Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Race Oncology Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Race Oncology Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Race Oncology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRace Oncology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Race Oncology Ltd. The current adx is 18.15.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Race Oncology Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Race Oncology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Race Oncology Ltd. The current sar is 1.75907147.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Race Oncology Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Race Oncology Ltd. The current rsi is 55.49. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Race Oncology Ltd Daily Relative Strength Index (RSI) ChartRace Oncology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Race Oncology Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Race Oncology Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Race Oncology Ltd Daily Stochastic Oscillator ChartRace Oncology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Race Oncology Ltd. The current cci is 64.14.

Race Oncology Ltd Daily Commodity Channel Index (CCI) ChartRace Oncology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Race Oncology Ltd. The current cmo is 16.87.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Race Oncology Ltd Daily Chande Momentum Oscillator (CMO) ChartRace Oncology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Race Oncology Ltd. The current willr is -38.88888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Race Oncology Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Race Oncology Ltd Daily Williams %R ChartRace Oncology Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Race Oncology Ltd.

Race Oncology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Race Oncology Ltd. The current atr is 0.08361101.

Race Oncology Ltd Daily Average True Range (ATR) ChartRace Oncology Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Race Oncology Ltd. The current obv is 639,196.

Race Oncology Ltd Daily On-Balance Volume (OBV) ChartRace Oncology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Race Oncology Ltd. The current mfi is 45.05.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Race Oncology Ltd Daily Money Flow Index (MFI) ChartRace Oncology Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Race Oncology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-30STOCH LONG EXITThe %K line crosses below th